Issue 6/2020
Content (16 Articles)
Acknowledgement to Referees
Targeting Nuclear Export Proteins in Multiple Myeloma Therapy
Nicholas Theodoropoulos, Guido Lancman, Ajai Chari
Poly(ADP-Ribose) Polymerase Inhibitors in Prostate Cancer: Molecular Mechanisms, and Preclinical and Clinical Data
Dawid Sigorski, Ewa Iżycka-Świeszewska, Lubomir Bodnar
Everolimus in Advanced Breast Cancer: A Systematic Review and Meta-analysis
Jacques Raphael, Cory Lefebvre, Alison Allan, Joelle Helou, Gabriel Boldt, Theodore Vandenberg, Phillip S Blanchette
Cetuximab in Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Ovarian Cancer Without KRAS, NRAS, or BRAF Mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Julie G. Fisher, David Tait, Elizabeth Garrett-Mayer, Susan Halabi, Pam K. Mangat, Julian C. Schink, Ricardo H. Alvarez, Dan Veljovich, Timothy L. Cannon, Pamela A. Crilley, Theodore Pollock, Carmen J. Calfa, Tareq Al Baghdadi, Ramya Thota, Nicole Fleming, Jared A. Cotta, Andrew L. Rygiel, Sasha L. Warren, Richard L. Schilsky
Sunitinib in Patients with Metastatic Colorectal Cancer (mCRC) with FLT-3 Amplification: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Tareq Al Baghdadi, Elizabeth Garrett-Mayer, Susan Halabi, Pam K. Mangat, Patricia Rich, Eugene R. Ahn, Seungjean Chai, Andrew L. Rygiel, Olufunlayo Osayameh, Kaitlyn R. Antonelli, Samiha Islam, Suanna S. Bruinooge, Richard L. Schilsky
Rechallenge with Anti-EGFR Therapy in Metastatic Colorectal Cancer (mCRC): Results from South Australia mCRC Registry
Li Chia Chong, Jennifer E. Hardingham, Amanda R. Townsend, Cynthia Piantadosi, Gonzalo Tapia Rico, Chris Karapetis, Rob Padbury, Guy Maddern, Amitesh Roy, Timothy J. Price
A Melanoma-Tailored Next-Generation Sequencing Panel Coupled with a Comprehensive Analysis to Improve Routine Melanoma Genotyping
Baptiste Louveau, Fanélie Jouenne, Pauline Têtu, Aurélie Sadoux, Aurélia Gruber, Eddie Lopes, Julie Delyon, Kevin Serror, Oren Marco, Laetitia Da Meda, Aminata Ndiaye, Alban Lermine, Nicolas Dumaz, Maxime Battistella, Barouyr Baroudjian, Céleste Lebbe, Samia Mourah
Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma
Giulia Orsi, Francesco Tovoli, Vincenzo Dadduzio, Caterina Vivaldi, Oronzo Brunetti, Luca Ielasi, Fabio Conti, Giulia Rovesti, Laura Gramantieri, Mario Domenico Rizzato, Irene Pecora, Antonella Argentiero, Federica Teglia, Sara Lonardi, Francesca Salani, Alessandro Granito, Vittorina Zagonel, Giorgia Marisi, Giuseppe Cabibbo, Francesco Giuseppe Foschi, Francesca Benevento, Alessandro Cucchetti, Fabio Piscaglia, Stefano Cascinu, Mario Scartozzi, Andrea Casadei-Gardini
Correction to: Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE‑2 Study
Luca Faloppi, Marco Puzzoni, Andrea Casadei Gardini, Nicola Silvestris, Gianluca Masi, Giorgia Marisi, Caterina Vivaldi, Cosmo Damiano Gadaleta, Pina Ziranu, Maristella Bianconi, Cristian Loretelli, Laura Demurtas, Eleonora Lai, Riccardo Giampieri, Eva Galizia, Paola Ulivi, Nicola Battelli, Alfredo Falcone, Stefano Cascinu, Mario Scartozzi
Correction to: Phase Ib Trial of the PI3K Inhibitor Copanlisib Combined with the Allosteric MEK Inhibitor Refametinib in Patients with Advanced Cancer
Ramesh K. Ramanathan, Daniel D. Von Hoff, Ferry Eskens, George Blumenschein Jr., Donald Richards, Isabelle Genvresse, Susanne Reschke, Camille Granvil, Adam Skubala, Carol Peña, Klaus Mross
Correction to: Biologic Drug Quality Assurance to Optimize HER2+ Breast Cancer Treatment: Insights from Development of the Trastuzumab Biosimilar SB3
Diana Lüftner, Gary H. Lyman, João Gonçalves, Xavier Pivot, Minji Seo
Correction to: Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference Product
Dietger Niederwieser, Caroline Hamm, Patrick Cobb, Mindy Mo, Cecily Forsyth, Alessandra Tucci, Vladimir Hanes, Vincent Delwail, Roman Hajek, David Chien
Correction to: Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma
Giulia Orsi, Francesco Tovoli, Vincenzo Dadduzio, Caterina Vivaldi, Oronzo Brunetti, Luca Ielasi, Fabio Conti, Giulia Rovesti, Laura Gramantieri, Mario Domenico Rizzato, Irene Pecora, Antonella Argentiero, Federica Teglia, Sara Lonardi, Francesca Salani, Alessandro Granito, Vittorina Zagonel, Giorgia Marisi, Giuseppe Cabibbo, Francesco Giuseppe Foschi, Francesca Benevento, Alessandro Cucchetti, Fabio Piscaglia, Stefano Cascinu, Mario Scartozzi, Andrea Casadei-Gardini